Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Blood Reviews|July 28, 2019
Update on mutations in the HIF: EPO pathway and their role in erythrocytosisTerence R Lappin, Frank S LeeMethods in Molecular Biology (Clifton, N.J.)|March 12, 2009
Complete array of HOX gene expression by RQ-PCRGlenda J Dickson, Terence R Lappin, Alexander ThompsonStem Cells (Dayton, Ohio)|November 29, 2002
EPO's alter ego: erythropoietin has multiple actionsTerence R Lappin, A Peter Maxwell, Patrick G JohnstonStem Cells Translational Medicine|January 21, 2021
Erythropoietin in bone homeostasis-Implications for efficacious anemia therapyKatrina M Lappin, Ken I Mills, Terence R LappinCritical Reviews in Oncology/Hematology|July 28, 2007
Pathophysiology of anemia and erythrocytosisVivien M Hodges, Susan Rainey, Terence R Lappin, et al.Journal of Pediatric Hematology/Oncology|May 26, 2012
Methemoglobin reductase deficiency: novel mutation is associated with a disease phenotype of intermediate severityMelanie J Percy, Chris Barnes, Gemma Crighton, et al.Leukemia & Lymphoma|October 23, 2002
AINT/ERIC/TACC: an expanding family of proteins with C-terminal coiled coil domainsTerence R Lappin, Robert N Mullan, J Peter Stewart, et al.Journal of Experimental & Clinical Cancer Research : CR|September 1, 2011
Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinomaKaty S Orr, Zhanzhong Shi, W Mark Brown, et al.Oncotarget|October 11, 2014
POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in head and neck cancerDaniel J Sharpe, Katy S Orr, Michael Moran, et al.The American Journal of Pathology|June 22, 2011
The role of Pea3 group transcription factors in esophageal squamous cell carcinomaHiu-Fung Yuen, Cian M McCrudden, Ka-Kui Chan, et al.Pageof 2